Oxamniquine

This classification denotes an antihelminthic agent with the molecular formula C14H21N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0O977R722D, chemically known as 1,2,3,4-tetrahydro-2-((isopropylamino)methyl)-7-nitro-6-quinolinemethanol but generally known as oxamniquine, which bears US NIH Compound Identifier 4612. European Medicines Agency schedules Oxamniquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09494MIG. The term OXAMNIQUINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules oxamniquine in its Anatomical Therapeutic Chemical (ATC) Classification. OXAMNIQUINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxamniquine under HS 29334990 and SITC 51575. As of Q4 2014, OXAMNIQUINE remains the US FDA Preferred Term for this commodity. Oxamniquine bears US NLM identifiers UMLS ID C0029994 and NCI Concept Code C66258. SMILES: OCC1CC2CCC(NC2CC1[N](=O)O)CNC(C)C.